Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_02739 | 17 | 0.36 | Mlig455_050666 | Neo: - Age: - |
Mlig455_050666 {REF} {Length: 1033} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=25.9]} {RNA1509_42342} {RNA1310_4557} {RNA815_16034.1} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | -1.44 | 0.672 | 0.99971 | 1.00000 | |
RegionR2 | 0.683 | 0.672 | 0.65440 | 0.98822 | |
RegionR3 | -1.047 | 0.672 | 0.99943 | 1.00000 | |
RegionR4 | -0.63 | 0.672 | 0.81532 | 1.00000 | |
RegionR5 | -1.411 | 0.672 | 0.99939 | 1.00000 | |
RegionR6 | 5.22 | 0.672 | 0.26041 | 0.84808 | |
RegionR7 | -0.837 | 0.672 | 0.99947 | 1.00000 | |
RegionR8 | -0.538 | 0.672 | 1.00000 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -0.165 | 0.672 | 1.00000 | 1.00000 | |
RegenerationR2 | 0.735 | 0.672 | 0.69145 | 0.95337 | |
RegenerationR3 | -0.249 | 0.672 | 1.00000 | 1.00000 | |
RegenerationR4 | -1.204 | 0.672 | 0.36015 | 0.78723 | |
RegenerationR5 | 1.444 | 0.672 | 0.75067 | 0.97221 | |
RegenerationR6 | -5.817 | 0.672 | 0.14604 | 0.46813 | |
RegenerationBL | -2.376 | 0.672 | 0.99953 | 1.00000 | |
RegenerationTP | 1.749 | 0.672 | 0.77512 | 1.00000 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_02739 | 17 | 0.36 | Mlig455_050666 | Neo: - Age: - |
2 | 1.000 | - | - | - | 1.000 | - | Mlig455_050666 {REF} {Length: 1033} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=25.9]} {RNA1509_42342} {RNA1310_4557} {RNA815_16034.1} | |
2. | MligTC455_10386 | 40 | 0.84 | Mlig455_016460, Mlig455_016526, Mlig455_049813 | Neo: - Age: Up-Down-Down |
CHRNA2, CHRNA6 | 1.835 | 0.950 | - | - | - | 0.885 | - | Mlig455_016460 {REF} {Length: 2441} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=9e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=5e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=3e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=5e-148]} {RNA1310_41035} {RNA815_43177} Mlig455_016526 {REF} {Length: 2438} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.6]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=111.5]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=211, Expect=8e-61]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=214, Expect=4e-62]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=211, Expect=1e-60]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=216, Expect=6e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=210, Expect=8e-61]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=4e-148]} {RNA1310_41035} {RNA815_43177} Mlig455_049813 {REF} {Length: 2457} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=156.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=109.6]} {Human: ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=209, Expect=5e-60]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=207, Expect=1e-59]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=6e-57]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=3e-57]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=201, Expect=5e-57]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=201, Expect=6e-56]} {Mouse: ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=213, Expect=1e-61]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=212, Expect=1e-61]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=204, Expect=2e-58]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=203, Expect=6e-57]} {Dmel: FBgn0004118, nAChRbeta2, nicotinic Acetylcholine Receptor beta2, [Score=217, Expect=4e-63]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=209, Expect=1e-60]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=439, Expect=3e-148]} {RNA1310_41035} {RNA815_43177} |
3. | MligTC455_37096 | 119 | 2.49 | Mlig455_050902 | Neo: - Age: - Region-enriched R6: 4.558/0.00557 |
PXDN | 0.995 | 0.995 | - | - | - | - | - | Mlig455_050902 {REF} {Length: 3987} {Pfam: Animal haem peroxidase [PF03098.17, score=504.8]; Immunoglobulin domain [PF13927.8, score=48.3]; Immunoglobulin I-set domain [PF07679.18, score=46.6]; Immunoglobulin domain [PF00047.27, score=29.7]; Immunoglobulin domain [PF13895.8, score=20.9]} {Human: ENSG00000130508, PXDN, peroxidasin, [Score=452, Expect=3e-139]} {Mouse: ENSMUSG00000020674, Pxdn, peroxidasin, [Score=446, Expect=4e-138]} {Dmel: FBgn0011828, Pxn, Peroxidasin, [Score=424, Expect=6e-129]} {Celegans: WBGene00004256, pxn-1, Peroxidasin homolog, [Score=403, Expect=8e-123]} {Smed: dd_Smed_v6_3603_0_1, dd_Smed_v6_3603_0_1, [Score=499, Expect=7e-160]} {RNA1509_8453} {RNA1310_4027} {RNA815_967.1} |
4. | MligTC455_07822 | 103 | 2.14 | Mlig455_009973 | Neo: - Age: - Region-enriched R6: 8.220/0.00000 |
0.992 | 0.992 | - | - | - | - | - | Mlig455_009973 {REF} {Length: 1584} {RNA1310_20970} {RNA815_31710} | |
5. | MligTC455_18525 | 187 | 3.9 | Mlig455_011761, Mlig455_047975, Mlig455_066356, Mlig455_066357 | Neo: - Age: - |
HAL | 0.991 | 0.991 | - | - | - | - | - | Mlig455_011761 {REF} {Length: 2777} {Pfam: Aromatic amino acid lyase [PF00221.21, score=630.6]} {Human: ENSG00000084110, HAL, histidine ammonia-lyase, [RH, Score=834, Expect=0.0]} {Mouse: ENSMUSG00000020017, Hal, histidine ammonia lyase, [RH, Score=839, Expect=0.0]} {Celegans: WBGene00009813, haly-1, Histidine ammonia-lyase, [RH, Score=654, Expect=0.0]} {Smed: dd_Smed_v6_2219_0_1, dd_Smed_v6_2219_0_1, [RH, Score=455, Expect=2e-156]} {RNA1509_12711} {RNA1310_10590} {RNA815_24023} Mlig455_047975 {REF} {Length: 3006} {Pfam: Aromatic amino acid lyase [PF00221.21, score=630.6]} {Human: ENSG00000084110, HAL, histidine ammonia-lyase, [RH, Score=834, Expect=0.0]} {Mouse: ENSMUSG00000020017, Hal, histidine ammonia lyase, [RH, Score=839, Expect=0.0]} {Celegans: WBGene00009813, haly-1, Histidine ammonia-lyase, [RH, Score=654, Expect=0.0]} {Smed: dd_Smed_v6_2219_0_1, dd_Smed_v6_2219_0_1, [RH, Score=455, Expect=2e-156]} {RNA1509_12711} {RNA1310_10590, RNA1509_12711} {RNA1509_12711, RNA815_24023} Mlig455_066356 {REF} {Length: 262} {Pfam: Aromatic amino acid lyase [PF00221.21, score=93.1]} {Human: ENSG00000084110, HAL, histidine ammonia-lyase, [Score=119, Expect=4e-33]} {Mouse: ENSMUSG00000020017, Hal, histidine ammonia lyase, [Score=122, Expect=4e-34]} {Celegans: WBGene00009813, haly-1, Histidine ammonia-lyase, [Score=102, Expect=2e-27]} {Smed: dd_Smed_v6_2219_0_1, dd_Smed_v6_2219_0_1, [Score=133, Expect=1e-39]} {RNA1509_25146} {RNA1310_10590} {RNA815_24023} Mlig455_066357 {REF} {Length: 1013} {Pfam: Aromatic amino acid lyase [PF00221.21, score=49.5]} {Human: ENSG00000084110, HAL, histidine ammonia-lyase, [Score=125, Expect=3e-34]} {Mouse: ENSMUSG00000020017, Hal, histidine ammonia lyase, [Score=124, Expect=3e-33]} {Celegans: WBGene00009813, haly-1, Histidine ammonia-lyase, [Score=104, Expect=1e-26]} {Smed: dd_Smed_v6_2219_0_1, dd_Smed_v6_2219_0_1, [Score=106, Expect=3e-28]} {RNA1509_25146} {RNA1310_10590} {RNA815_24023} |
6. | MligTC455_53341 | 1321 | 27.52 | Mlig455_026459, Mlig455_044751 | Neo: - Age: - Region-enriched R7: 7.097/0.00000 Regeneration-downregulated BL: -10.182 Regeneration-depleted BL: -10.182 |
0.987 | 0.987 | - | - | - | - | - | Mlig455_026459 {REF} {Length: 739} {RNA1509_35464} {RNA1310_60456.2} {RNA815_44529} Mlig455_044751 {REF} {Length: 902} {RNA1509_35464} {RNA1310_60456.2, RNA1509_35464} {RNA1509_35464, RNA815_44529} |
|
7. | MligTC455_33806 | 93 | 1.94 | Mlig455_009560 | Neo: - Age: Up-Down-Up Region-enriched R6: 5.229/0.00001 |
MOXD1 | 0.985 | 0.985 | - | - | - | - | - | Mlig455_009560 {REF} {Length: 2463} {Pfam: Copper type II ascorbate-dependent monooxygenase, N-terminal domain [PF01082.22, score=94.2]; Copper type II ascorbate-dependent monooxygenase, C-terminal domain [PF03712.17, score=54.5]} {Human: ENSG00000079931, MOXD1, monooxygenase DBH like 1, [Score=110, Expect=1e-24]} {Mouse: ENSMUSG00000020000, Moxd1, monooxygenase, DBH-like 1, [Score=115, Expect=1e-26]} {Dmel: FBgn0010329, Tbh, Tyramine beta hydroxylase, [Score=124, Expect=2e-29]} {Celegans: WBGene00006541, tbh-1, Tyramine beta-hydroxylase, [Score=134, Expect=6e-33]} {Smed: dd_Smed_v6_42610_0_1, dd_Smed_v6_42610_0_1, [Score=115, Expect=6e-28]} {RNA1509_32991} {RNA1310_25882} {RNA815_12058} |
8. | MligTC455_37927 | 29 | 0.59 | Mlig455_005071, Mlig455_014052, Mlig455_025140, Mlig455_039469, Mlig455_070126 | Neo: - Age: - |
0.985 | 0.985 | - | - | - | - | - | Mlig455_005071 {REF} {Length: 965} {Pfam: Myb/SANT-like DNA-binding domain [PF13873.8, score=28.7]; Myb/SANT-like DNA-binding domain [PF13837.8, score=20.2]} {RNA1310_46038} Mlig455_014052 {REF} {Length: 1489} {Pfam: Myb/SANT-like DNA-binding domain [PF13873.8, score=32.8]; Myb/SANT-like DNA-binding domain [PF13837.8, score=22.5]} {RNA1310_68333} Mlig455_025140 {REF} {Length: 761} {Pfam: Myb/SANT-like DNA-binding domain [PF13873.8, score=35.9]; Myb/SANT-like DNA-binding domain [PF13837.8, score=23.0]} {RNA1310_46038} Mlig455_039469 {REF} {Length: 1212} {Pfam: Myb/SANT-like DNA-binding domain [PF13873.8, score=25.1]} {RNA1310_46038} {RNA815_30681} Mlig455_070126 {REF} {Length: 1489} {Pfam: Myb/SANT-like DNA-binding domain [PF13873.8, score=32.8]; Myb/SANT-like DNA-binding domain [PF13837.8, score=22.5]} {RNA1310_68333} |
|
9. | MligTC455_47733 | 81 | 1.69 | Mlig455_044125 | Neo: - Age: logFC(26M/2M)=0.424 Region-enriched R6: 4.050/0.00363 Regeneration-downregulated R6: -6.610 Regeneration-depleted R6: -6.610 |
0.985 | 0.985 | - | - | - | - | - | Mlig455_044125 {REF} {Length: 4219} {Pfam: Peptidase family M13 [PF05649.15, score=42.8]} {RNA1310_43623} {RNA815_36140} | |
10. | MligTC455_13729 | 55 | 1.15 | Mlig455_025374, Mlig455_025422 | Neo: - Age: Up-Down-Up |
0.983 | 0.983 | - | - | - | - | - | Mlig455_025374 {REF} {Length: 2416} {Pfam: Innexin [PF00876.20, score=384.4]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=107, Expect=2e-25]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=358, Expect=8e-122]} {Smed: dd_Smed_v6_11077_0_2, dd_Smed_v6_11077_0_2, [Score=351, Expect=1e-117]} {RNA1310_71151} {RNA815_44601} Mlig455_025422 {REF} {Length: 2321} {Pfam: Innexin [PF00876.20, score=381.6]} {Dmel: FBgn0027108, Inx2, Innexin 2, [Score=105, Expect=4e-25]} {Celegans: WBGene00002123, inx-1, Innexin, [Score=355, Expect=1e-120]} {Smed: dd_Smed_v6_11077_0_1, dd_Smed_v6_11077_0_1, [Score=358, Expect=9e-121]} {RNA1310_71151} {RNA815_44601} |
|
11. | MligTC455_34886 | 2093 | 43.6 | Mlig455_064083 | Neo: - Age: Up-Down-Down Region-specific R6: 7.007 Region-enriched R6: 7.819/0.00000 |
ZAN | 0.983 | 0.983 | - | - | - | - | - | Mlig455_064083 {REF} {Length: 17387} {Pfam: von Willebrand factor type A domain [PF00092.30, score=31.8]} {Human: ENSG00000146839, ZAN, zonadhesin (gene/pseudogene), [Score=86.7, Expect=2e-15]} {Mouse: ENSMUSG00000079173, Zan, zonadhesin, [Score=76.3, Expect=2e-12]; ENSMUSG00000047730, Fcgbp, Fc fragment of IgG binding protein, [Score=72.8, Expect=2e-11]} {Smed: dd_Smed_v6_91_0_1, dd_Smed_v6_91_0_1, [Score=224, Expect=8e-58]} {RNA1509_265, RNA1509_35674} {RNA1310_18.1, RNA1509_35674} {RNA1509_35674, RNA815_11} |
12. | MligTC455_36190 | 239 | 4.99 | Mlig455_011419 | Neo: - Age: - Region-enriched R6: 8.371/0.00000 |
GLIPR1 | 0.983 | 0.983 | - | - | - | - | - | Mlig455_011419 {REF} {Length: 1624} {Pfam: Cysteine-rich secretory protein family [PF00188.28, score=61.8]} {Human: ENSG00000139278, GLIPR1, GLI pathogenesis related 1, [Score=76.6, Expect=3e-15]} {Mouse: ENSMUSG00000078949, R3hdml, R3H domain containing-like, [Score=73.2, Expect=3e-14]; ENSMUSG00000024011, Pi16, peptidase inhibitor 16, [Score=70.9, Expect=6e-13]} {Dmel: FBgn0038126, CG8483, [Score=72.0, Expect=1e-13]} {Celegans: WBGene00015246, scl-23, SCP-Like extracellular protein, [RH, Score=58.5, Expect=2e-09]} {Smed: dd_Smed_v6_6756_0_1, dd_Smed_v6_6756_0_1, [Score=96.3, Expect=3e-23]} {RNA1509_16373} {RNA1310_19845.1} {RNA815_8030} |
13. | MligTC455_15441 | 62 | 1.29 | Mlig455_037158 | Neo: - Age: - |
0.977 | - | - | - | - | 0.977 | - | Mlig455_037158 {REF} {Length: 2997} {Pfam: RNA repair pathway DNA polymerase beta family [PF10127.11, score=20.8]} {RNA1509_39460} {RNA1310_16073.2} {RNA815_15926} | |
14. | MligTC455_22577 | 13 | 0.27 | Mlig455_058663, Mlig455_058678 | Neo: - Age: - |
0.975 | 0.975 | - | - | - | - | - | Mlig455_058663 {REF} {Length: 467} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_41224} {RNA1310_32946.2} {RNA815_39194} Mlig455_058678 {REF} {Length: 467} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_41224} {RNA1310_32946.2} {RNA815_39194} |
|
15. | MligTC455_45467 | 192 | 4 | Mlig455_050191, Mlig455_066984 | Neo: - Age: - |
ANKFN1 | 0.972 | - | - | - | - | 0.972 | - | Mlig455_050191 {REF} {Length: 3774} {RNA1310_116740} {RNA815_60563} Mlig455_066984 {REF} {Length: 4097} {Human: ENSG00000153930, ANKFN1, ankyrin repeat and fibronectin type III domain containing 1, [RH, Score=213, Expect=7e-56]} {Mouse: ENSMUSG00000047773, Ankfn1, ankyrin-repeat and fibronectin type III domain containing 1, [RH, Score=200, Expect=6e-52]} {Dmel: FBgn0266418, wake, wide awake, [Score=177, Expect=9e-45]} {Celegans: WBGene00019935, R07E4.1, [RH, Score=139, Expect=3e-33]} {Smed: dd_Smed_v6_6406_0_1, dd_Smed_v6_6406_0_1, [Score=265, Expect=4e-73]} {RNA1310_116740} {RNA815_60563} |
16. | MligTC455_35870 | 19 | 0.4 | Mlig455_065478 | Neo: - Age: - |
0.971 | 0.971 | - | - | - | - | - | Mlig455_065478 {REF} {Length: 942} {RNA1310_89037} | |
17. | MligTC455_36758 | 1551 | 32.3 | Mlig455_034048 | Neo: - Age: Up-Down-Down Region-enriched R6: 7.207/0.00000 |
0.971 | 0.971 | - | - | - | - | - | Mlig455_034048 {REF} {Length: 7277} {Smed: dd_Smed_v6_52973_0_1, dd_Smed_v6_52973_0_1, [Score=106, Expect=4e-23]} {RNA1509_301} {RNA1310_15} {RNA815_1011.1} | |
18. | MligTC455_18814 | 44 | 0.91 | Mlig455_001664 | Neo: - Age: Up-Down-Up |
0.969 | 0.969 | - | - | - | - | - | Mlig455_001664 {REF} {Length: 1673} {Smed: dd_Smed_v6_18585_0_1, dd_Smed_v6_18585_0_1, [Score=100, Expect=1e-23]} {RNA1310_49005} {RNA815_48672} | |
19. | MligTC455_11193 | 38 | 0.79 | Mlig455_061638 | Neo: - |
GABRA6 | 0.967 | 0.967 | - | - | - | - | - | Mlig455_061638 {REF} {Length: 1770} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=160.9]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=102.2]} {Human: ENSG00000145863, GABRA6, gamma-aminobutyric acid type A receptor alpha6 subunit, [RH, Score=301, Expect=1e-97]; ENSG00000151834, GABRA2, gamma-aminobutyric acid type A receptor alpha2 subunit, [RH, Score=300, Expect=7e-97]; ENSG00000186297, GABRA5, gamma-aminobutyric acid type A receptor alpha5 subunit, [RH, Score=290, Expect=5e-93]; ENSG00000022355, GABRA1, gamma-aminobutyric acid type A receptor alpha1 subunit, [RH, Score=290, Expect=7e-93]; ENSG00000011677, GABRA3, gamma-aminobutyric acid type A receptor alpha3 subunit, [RH, Score=286, Expect=3e-91]; ENSG00000109158, GABRA4, gamma-aminobutyric acid type A receptor alpha4 subunit, [RH, Score=286, Expect=3e-90]} {Mouse: ENSMUSG00000020428, Gabra6, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 6, [RH, Score=303, Expect=2e-98]; ENSMUSG00000000560, Gabra2, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2, [RH, Score=300, Expect=3e-97]; ENSMUSG00000055078, Gabra5, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 5, [RH, Score=290, Expect=6e-93]; ENSMUSG00000010803, Gabra1, gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1, [RH, Score=289, Expect=6e-93]} {Dmel: FBgn0030707, CG8916, [Score=323, Expect=1e-105]} {Celegans: WBGene00013914, lgc-37, Ligand-Gated ion Channel, [RH, Score=300, Expect=3e-97]} {Smed: dd_Smed_v6_24908_0_1, dd_Smed_v6_24908_0_1, [RH, Score=429, Expect=3e-148]} {RNA1310_23972} {RNA815_15667.1} |
20. | MligTC455_02837 | 29 | 0.61 | Mlig455_004700 | Neo: - Age: - Region-enriched R6: 6.687/0.01418 |
0.966 | 0.966 | - | - | - | - | - | Mlig455_004700 {REF} {Length: 1630} {RNA1509_44223} {RNA1310_194.1} {RNA815_27158} | |
21. | MligTC455_37167 | 94 | 1.97 | Mlig455_051119, Mlig455_068293 | Neo: - Age: - |
0.966 | - | - | - | - | 0.966 | - | Mlig455_051119 {REF} {Length: 1310} {NoTransDecoderORF} {RNA1310_80822} Mlig455_068293 {REF} {Length: 276} {NoTransDecoderORF} {RNA1310_69701.1} |
|
22. | MligTC455_17565 | 85 | 1.77 | Mlig455_054318 | Neo: - Age: - Region-enriched R2: 6.111/0.00708 |
0.963 | - | - | - | - | 0.963 | - | Mlig455_054318 {REF} {Length: 550} {RNA1310_73705} {RNA815_38857} | |
23. | MligTC455_02903 | 85 | 1.78 | Mlig455_034050 | Neo: - Age: Up-Down-Up, logFC(26M/2M)=0.689 Region-enriched R6: 6.316/0.00001 |
0.962 | 0.962 | - | - | - | - | - | Mlig455_034050 {REF} {Length: 403} {Smed: dd_Smed_v6_1636_0_1, dd_Smed_v6_1636_0_1, [Score=62.4, Expect=3e-11]} {RNA1509_301} {RNA1310_15} {RNA815_90} | |
24. | MligTC455_22736 | 174 | 3.62 | Mlig455_036576 | Neo: - Age: - Region-enriched R6: 5.263/0.00000 Regeneration-depleted R6: -8.651 |
PHEX | 0.962 | 0.962 | - | - | - | - | - | Mlig455_036576 {REF} {Length: 3336} {Pfam: Peptidase family M13 [PF01431.23, score=134.4]; Peptidase family M13 [PF05649.15, score=87.9]} {Human: ENSG00000102174, PHEX, phosphate regulating endopeptidase homolog X-linked, [Score=155, Expect=1e-38]; ENSG00000284917, EEF1AKMT4-ECE2, EEF1AKMT4-ECE2 readthrough, [Score=154, Expect=3e-38]; ENSG00000145194, ECE2, endothelin converting enzyme 2, [Score=154, Expect=2e-38]; ENSG00000196549, MME, membrane metalloendopeptidase, [Score=148, Expect=2e-36]} {Mouse: ENSMUSG00000022842, Ece2, endothelin converting enzyme 2, [Score=152, Expect=6e-38]; ENSMUSG00000115293, Gm49333, predicted gene, 49333, [Score=152, Expect=8e-38]; ENSMUSG00000027820, Mme, membrane metallo endopeptidase, [Score=148, Expect=1e-36]; ENSMUSG00000057457, Phex, phosphate regulating endopeptidase homolog, X-linked, [Score=146, Expect=6e-36]} {Dmel: FBgn0031081, Nep3, Neprilysin 3, [Score=135, Expect=2e-32]} {Celegans: WBGene00013926, nep-1, Neprilysin-1, [Score=155, Expect=4e-39]} {Smed: dd_Smed_v6_8276_0_1, dd_Smed_v6_8276_0_1, [Score=149, Expect=3e-37]} {RNA1509_47798} {RNA1310_6773, RNA1509_47798} {RNA1509_47798, RNA815_4414} |
25. | MligTC455_32522 | 134 | 2.8 | Mlig455_040944 | Neo: - Age: - |
0.961 | - | - | - | - | 0.961 | - | Mlig455_040944 {REF} {Length: 2473} {RNA1509_46835} {RNA1310_21335.2} {RNA815_21965} | |
26. | MligTC455_16014 | 135 | 2.81 | Mlig455_057808 | Neo: - Age: - |
SLC6A3 | 0.96 | 0.960 | - | - | - | - | - | Mlig455_057808 {REF} {Length: 3595} {tRNA: Undet(NNN),pseudo, score=28.6} {Pfam: Sodium:neurotransmitter symporter family [PF00209.20, score=586.5]} {Human: ENSG00000142319, SLC6A3, solute carrier family 6 member 3, [Score=521, Expect=1e-177]; ENSG00000276996, SLC6A3, solute carrier family 6 member 3, [Score=521, Expect=1e-177]; ENSG00000103546, SLC6A2, solute carrier family 6 member 2, [Score=505, Expect=1e-171]} {Mouse: ENSMUSG00000021609, Slc6a3, solute carrier family 6 (neurotransmitter transporter, dopamine), member 3, [Score=523, Expect=1e-178]; ENSMUSG00000055368, Slc6a2, solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, [Score=511, Expect=3e-174]} {Dmel: FBgn0010414, SerT, Serotonin transporter, [Score=468, Expect=2e-157]} {Celegans: WBGene00000934, dat-1, Sodium-dependent dopamine transporter, [Score=433, Expect=4e-144]} {Smed: dd_Smed_v6_22486_0_1, dd_Smed_v6_22486_0_1, [RH, Score=571, Expect=0.0]} {RNA1509_41282} {RNA1310_11169, RNA1509_41282} {RNA1509_41282, RNA815_3966} |
27. | MligTC455_32201 | 49 | 1.03 | Mlig455_026554 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_026554 {REF} {Length: 2504} {Pfam: CENP-B N-terminal DNA-binding domain [PF04218.15, score=24.6]} {RNA1310_5930} {RNA815_21829} | |
28. | MligTC455_53656 | 27 | 0.57 | Mlig455_033327 | Neo: - Age: - |
0.956 | - | - | - | - | 0.956 | - | Mlig455_033327 {REF} {Length: 1116} {Smed: dd_Smed_v6_91651_0_1, dd_Smed_v6_91651_0_1, [Score=43.9, Expect=6e-06]} {RNA1509_48973} {RNA1310_39833} {RNA815_36286} | |
29. | MligTC455_29361 | 135 | 2.82 | Mlig455_037251 | Neo: - Age: - |
0.955 | - | - | - | - | 0.955 | - | Mlig455_037251 {REF} {Length: 608} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_38215} {RNA1310_46814} {RNA815_22703.1} | |
30. | MligTC455_06856 | 18 | 0.37 | Mlig455_022133 | Neo: - Age: - |
0.954 | - | - | - | - | 0.954 | - | Mlig455_022133 {REF} {Length: 440} | |
31. | MligTC455_52788 | 41 | 0.86 | Mlig455_016296 | Neo: - Age: - |
FCN1 | 0.954 | - | - | - | - | 0.954 | - | Mlig455_016296 {REF} {Length: 1559} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=167.4]} {Human: ENSG00000085265, FCN1, ficolin 1, [Score=141, Expect=2e-39]; ENSG00000160339, FCN2, ficolin 2, [Score=139, Expect=3e-39]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=134, Expect=2e-35]} {Mouse: ENSMUSG00000026938, Fcna, ficolin A, [RH, Score=135, Expect=4e-37]} {Dmel: FBgn0003326, sca, scabrous, [RH, Score=128, Expect=4e-33]} {Celegans: WBGene00020516, T15B7.1, [Score=59.3, Expect=6e-10]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=110, Expect=4e-27]} {RNA1310_57278} {RNA815_33549} |
32. | MligTC455_15150 | 7 | 0.14 | Mlig455_034554, Mlig455_041521 | Neo: Int S/G2/M Age: Up-Down-Down |
ELAVL1, ELAVL2 | 0.953 | - | - | - | - | 0.953 | - | Mlig455_034554 {REF} {Length: 2981} {TRANSSPLICED} {Pfam: Pyridoxal-phosphate dependent enzyme [PF00291.27, score=175.2]; RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=122.3]} {Human: ENSG00000066044, ELAVL1, ELAV like RNA binding protein 1, [Score=132, Expect=2e-33]; ENSG00000135094, SDS, serine dehydratase, [Score=126, Expect=4e-31]} {Mouse: ENSMUSG00000029596, Sdsl, serine dehydratase-like, [Score=145, Expect=8e-38]; ENSMUSG00000029597, Sds, serine dehydratase, [Score=141, Expect=1e-36]} {Dmel: FBgn0086675, fne, found in neurons, [Score=152, Expect=3e-40]} {Celegans: WBGene00001368, exc-7, [Score=139, Expect=3e-35]} {Smed: dd_Smed_v6_2842_0_1, dd_Smed_v6_2842_0_1, [Score=158, Expect=7e-40]} {RNA1509_17790, RNA1509_5868} {RNA1310_3456.1, RNA1509_17790} {RNA1509_17790, RNA815_18672} Mlig455_041521 {REF} {Length: 989} {TRANSSPLICED} {Pfam: RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) [PF00076.24, score=54.9]} {Human: ENSG00000107105, ELAVL2, ELAV like RNA binding protein 2, [Score=92.8, Expect=4e-24]; ENSG00000162374, ELAVL4, ELAV like RNA binding protein 4, [Score=90.5, Expect=6e-22]} {Mouse: ENSMUSG00000008489, Elavl2, ELAV like RNA binding protein 1, [Score=92.8, Expect=6e-25]; ENSMUSG00000028546, Elavl4, ELAV like RNA binding protein 4, [Score=91.7, Expect=2e-24]} {Dmel: FBgn0086675, fne, found in neurons, [Score=80.5, Expect=1e-18]} {Celegans: WBGene00001368, exc-7, [Score=80.5, Expect=1e-18]} {Smed: dd_Smed_v6_11311_0_1, dd_Smed_v6_11311_0_1, [Score=73.9, Expect=2e-17]} {RNA1509_5868} {RNA1310_4967.2} {RNA815_50264} |
33. | MligTC455_22737 | 119 | 2.47 | Mlig455_057775 | Neo: - Age: Down-Up-Down Region-enriched R6: 5.005/0.00000 Regeneration-downregulated R6: -7.253 Regeneration-depleted R6: -7.253 |
MMEL1 | 0.953 | 0.953 | - | - | - | - | - | Mlig455_057775 {REF} {Length: 3495} {Pfam: Peptidase family M13 [PF01431.23, score=134.6]; Peptidase family M13 [PF05649.15, score=84.7]} {Human: ENSG00000277131, MMEL1, membrane metalloendopeptidase like 1, [Score=164, Expect=1e-41]; ENSG00000142606, MMEL1, membrane metalloendopeptidase like 1, [Score=164, Expect=1e-41]} {Mouse: ENSMUSG00000115293, Gm49333, predicted gene, 49333, [Score=154, Expect=3e-38]; ENSMUSG00000022842, Ece2, endothelin converting enzyme 2, [Score=152, Expect=4e-38]; ENSMUSG00000027820, Mme, membrane metallo endopeptidase, [Score=150, Expect=3e-37]} {Dmel: FBgn0031081, Nep3, Neprilysin 3, [Score=138, Expect=2e-33]} {Celegans: WBGene00020230, nep-2, Neprilysin-2, [Score=156, Expect=2e-39]} {Smed: dd_Smed_v6_8276_0_1, dd_Smed_v6_8276_0_1, [Score=148, Expect=6e-37]} {RNA1509_47798} {RNA1310_6773} {RNA815_4414} |
34. | MligTC455_37914 | 71 | 1.47 | Mlig455_058565 | Neo: - Age: - |
NANOS3 | 0.952 | 0.952 | - | - | - | - | - | Mlig455_058565 {REF} {Length: 1346} {Pfam: Nanos RNA binding domain [PF05741.15, score=84.7]} {Human: ENSG00000187556, NANOS3, nanos C2HC-type zinc finger 3, [RH, Score=73.2, Expect=5e-16]} {Mouse: ENSMUSG00000051965, Nanos2, nanos C2HC-type zinc finger 2, [Score=77.0, Expect=3e-18]} {Dmel: FBgn0002962, nos, Nitric oxide synthase, [RH, Score=78.2, Expect=3e-17]} {Smed: dd_Smed_v6_10484_0_1, dd_Smed_v6_10484_0_1, [Score=89.7, Expect=1e-22]} {RNA1310_114488} |
35. | MligTC455_17448 | 5 | 0.11 | Mlig455_029739 | Neo: - Age: - |
0.951 | - | - | - | - | 0.951 | - | Mlig455_029739 {REF} {Length: 758} {NoTransDecoderORF} {RNA1310_32263} | |
36. | MligTC455_06102 | 9 | 0.19 | Mlig455_016363 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_016363 {REF} {Length: 711} {NoTransDecoderORF} {RNA1310_76160} {RNA815_19899} | |
37. | MligTC455_10178 | 77 | 1.6 | Mlig455_017978 | Neo: - Age: - Region-enriched R7: 6.377/0.00000 |
GRM3 | 0.95 | - | - | - | - | 0.950 | - | Mlig455_017978 {REF} {Length: 3464} {Pfam: Receptor family ligand binding region [PF01094.30, score=224.4]; 7 transmembrane sweet-taste receptor of 3 GCPR [PF00003.24, score=185.8]; Nine Cysteines Domain of family 3 GPCR [PF07562.16, score=39.1]} {Human: ENSG00000198822, GRM3, glutamate metabotropic receptor 3, [RH, Score=675, Expect=0.0]} {Mouse: ENSMUSG00000003974, Grm3, glutamate receptor, metabotropic 3, [RH, Score=670, Expect=0.0]; ENSMUSG00000023192, Grm2, glutamate receptor, metabotropic 2, [RH, Score=643, Expect=0.0]} {Dmel: FBgn0019985, mGluR, metabotropic Glutamate Receptor, [Score=725, Expect=0.0]} {Celegans: WBGene00003232, mgl-1, Probable metabotropic glutamate receptor mgl-1, [RH, Score=625, Expect=0.0]} {Smed: dd_Smed_v6_15419_0_1, dd_Smed_v6_15419_0_1, [RH, Score=803, Expect=0.0]} {RNA1310_41220} |
38. | MligTC455_17218 | 37 | 0.78 | Mlig455_053853 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_053853 {REF} {Length: 1743} {RNA1310_61921} | |
39. | MligTC455_39495 | 30 | 0.62 | Mlig455_037087 | Neo: - Age: - |
0.95 | - | - | - | - | 0.950 | - | Mlig455_037087 {REF} {Length: 1984} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=38.4]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=49.7, Expect=2e-06]} {RNA1310_19222} {RNA815_35367} |